• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Regulation mechanisms of the development of HLA-linked diseases by the complexes of HLA molecules and peptides.

Research Project

Project/Area Number 09470060
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Experimental pathology
Research InstitutionASAHIKAWA MEDICAL COLLEGE

Principal Investigator

KATAGIRI Makoto  Asahikawa Medical College, Vice-President, 副学長 (10041823)

Co-Investigator(Kenkyū-buntansha) KOBAYASHI Hiroya  Asahikawa Medical College, School of Medicine, Assistant, 医学部, 助手 (90280867)
SATO Keisuke  Asahikawa Medical College, School of Medicine, Assistant Professor, 医学部, 講師 (10250549)
KIMURA Shyoji  Asahikawa Medical College, School of Medicine, Professor, 医学部, 教授 (00250548)
AOKI Naoko  Asahikawa Medical College, School of Medicine, Assistant, 医学部, 助手 (60301983)
Project Period (FY) 1997 – 1999
KeywordsHLA molecules / HLA-binding peptides / Disease susceptibility / Allele-specific binding motif
Research Abstract

The profound polymorphism, one of the unique features of HLA molecules, is linked to (a positive association with) the development of certain diseases. Polymorphic region of HLA molecules interact with the corresponding peptides. The complexes then are presented to and stimulate specific T cells, leading to a variety of consequences. Thus the mode the binding of HLA molecules and peptides may affect the process of the development of HLA linked diseases.
The primary concern of this project has been the identification of specific peptides possibly involved in the pathogenesis of the diseases, examining the interaction of those peptides with HLA molecules and T cells, and subsequently controlling the disease process.
First we have identified the amino acid sequence of the peptides specifically bound to HLA-DR4 and HLA-DR9/DR53, depicting allele specific amino acid sequences (motif). Those two alleles are relatively common in Japanese and are known to have a linkage to certain diseases.
Next … More we have investigated peptides which may be involved in the development of such diseases as birch pollinosis, Vogt-Koyanagi-Harada disease and IDDM. We have also examined the possible tumor antigen of malignant melanoma.
Our results are summarized as follows,
1.Birch pollinosis has a positive association with HLA-DR9. A 17kDa protein has been identified to be a major T cell activating antigen. The protein held three HLA-DR9 restricted epitopes and they all bore DR9 specific binding motif. In patients who had no HLA-DR9 their T cells recognized the epitope containing HLA-DQI binding motif.
2.Harada's disease has a positive association with HLA-DR4. T cells from the patient recognized peptides derived from tyrosinase. The peptides bore HLA-DR4 binding motif.
3.I-AィイD1g7ィエD1 has a critical role in the development of insulitis and diabetes in NOD mice, a model of IDDM. Two major peptides from glutamic acid decarboxylase 65(GAD65) have been identified to stimulate T cells from NOD mice. Pretreatment of NOD mice with those peptides prevented the development of insulitis.
4.Tyrosinase was examined for the possible tumor antigen of malignant melanoma. T cells from melanoma patients recognized the peptide derived from tyrcosinase in HLA-DR15 restricted manner.
Our research will present a clue for better understanding a molecular mechanism of disease process and provide the basis for peptide therapy. Less

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] 水本桂子 他: "白樺花粉症抗原T細胞エピトープの解析"北海道医誌. 72. 59-67 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yusuke Abe et al: "Epitope analysis of birch pollen allergen in Japanese subjects"J.Clin.Immunol.. 17. 485-493 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hiroya Kobayashi et al: "CD4^+T cells from Peripheral Blood of a Melanoma Patient Recognize Peptides Derived from Nonmutated Tyrosinase"Cancer Res.. 58. 296-301 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hiroya Kobayashi et al: "Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient"Immunogenetics. 47. 398-403 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 佐藤啓介: "HLA分子結合ペプチド-免疫および疾患感受性制御を目指して-"移植. 34. 1-13 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takeshi Ogino et al: "Importance of GAD65 peptides and I-A^<g7> in the development of insulitis in NOD mice"Immunogenetics. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 片桐一: "主要組織適合系と移植・疾患感受性,新病理学会総論(菊地浩吉、吉木敬編)"南山堂,東京. 12 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Analysis of T cell Epitopes on Birch Pollen Allergen.: "Analysis of T cell Epitopes on Birch Pollen Allergen."Hokkaido J.Medi7cal Science. 72. 59-67 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yusuke Abe et al: "Epitope analysis of birch pollen allergen in Japanese subjects."J. Clin. Immunol.. 72. 485-493 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hiroya Kobayashi et al: "CD4+T cells from Peripheral Blood of a Melanoma Patient Recognize Peptides Derived from Nonmutated Tyrosinase."Cancer Res.. 58. 296-301 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hiroya Kobayashi et al: "Tyrosinase epitope recognized by an HLA-DR-restricted T-cell linefrom a Vogt-Koyanagi-Harada disease patient."Immunogenetics. 47. 398-403 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Keisuke Sato et al: "HLA-binding peptides 〜regulation of immunereacti and susceptlblllty of HLA-linked diseases〜"Isyoku. 34. 1-13 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takeshi Ogino et al: "Importance of GAD65 peptides and l-Ag7 in the development of insulitis in NOD mice."Immunogenetics. (in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi